Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

Abstract Background The tumor microenvironment is associated with prognosis in advanced non‐small cell lung carcinoma (NSCLC). The aim of this study was to explore the relationship between blood T cell diversity and survival of patients treated with pemetrexed‐based chemotherapy for nonsquamous NSCL...

Full description

Bibliographic Details
Main Authors: Li Qian, Zhang Zhaohui, Xu Yaping, Liu Zhentian, Liu Zhentao, Wang Qiqi, Gu Yangchun, Liu Yan'e, Yin Wencheng, Yi Fumei, Yao Yanhong, Cao Baoshan, Liang Li
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Thoracic Cancer
Subjects:
Advanced non‐small cell lung carcinoma
T cell diversity
tumor microenvironment
Online Access:https://doi.org/10.1111/1759-7714.13771

Internet

https://doi.org/10.1111/1759-7714.13771

Similar Items